Batavia Bioservices aims to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate medicines from discovery to the clinic.
In the rapidly growing market of biopharmaceuticals we offer our novel technologies and know how in order to help our customers to complete their preclinical phases in product development at higher speed, reduced cost, and with higher success rate.
read more >>
Current vacancies
Currently we are looking for (a):
- Technician biochemical assays
- Fulltime Executive Secretary
- Technician USP
- Technician USP on a temporary basis
- Technician DSP
read more >>
Batavia Bioservices and UvA Holding announce STEP(TM) technology exclusive license
Batavia Bioservices BV and UvA Holding BV announced today that they have successfully concluded an agreement granting Batavia Bioservices the exclusive rights to STEP(TM) technology developed by scientists at CellaGenics BV, an UvA Holding BV company.
read more >>
Batavia Bioservices Partners with Charles River
Working together, Batavia Bioservices and Charles River are now able to provide a single point of contact offering a seamless transition from cell line development through to cell banking, characterization, and clinical scale manufacturing of recombinant proteins, mAbs, gene therapies and virus products.
read more >>
Two new articles in Biotech News
Leiden, December, 2012
read more >>
Batavia Bioservices
Batavia Bioservices offers a portfolio of services focused on the rapid and cost effective provision of high quality biopharmaceutical materials for research and pre-clinical studies. Services include:
Batavia Bioservices is strongly committed to the development of new technologies and innovations within the field of biopharmaceutical research and development. We focus on technology which ultimately leads to the development of better medicines at reduced cost and time.